Phosphorylation of phosphoinositides in human platelets

Area of Science:

• Biochemistry
• Cell Biology
• Hematology

Background:

• Phosphatidylinositol (PI) lipids are crucial signaling molecules in human platelets.
• Cyclic adenosine monophosphate (cAMP) and intracellular calcium (Ca2+) are key regulators of platelet function.
• Understanding the regulation of PI metabolism is vital for platelet research.

Purpose of the Study:

• To investigate the effect of altered intracellular cAMP and Ca2+ levels on the 32P-labeling of phosphoinositides in intact human platelets.
• To determine the specific phosphoinositides affected by these signaling molecules.

Main Methods:

• Intact human platelets were labeled with 32P.
• Platelets were treated with agents that modify intracellular cAMP levels (dibutyryl cAMP, prostaglandin I2, phosphodiesterase inhibitor DN-9693).
• Intracellular Ca2+ was chelated using quin 2-AM.

Main Results:

• Increased 32P-labeling of PI-4-monophosphate (PIP) and decreased 32P-labeling of phosphatidylinositol (PI) were observed upon elevation of cAMP.
• Similar changes in PI and PIP labeling occurred with prostaglandin I2 and DN-9693 treatment.
• Chelation of intracellular Ca2+ also led to a significant, dose-dependent increase in PIP 32P-labeling.

Conclusions:

• PI kinase is activated by elevated intracellular cAMP levels in intact human platelets.
• PI kinase is also activated by the chelation of intracellular Ca2+ in intact human platelets.
• These findings elucidate novel regulatory mechanisms of PI metabolism in platelet signaling.